NCT01350609 - Pivotal Bioequivalence FDC Nifedipine / Candesartan vs. Loose Combination of Single Components, Fed | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

September 30, 2011

Conditions

Hypertension, Essential

Interventions

DRUG

Nifedipine/Candesartan (BAY 98-7106)

Fixed dose combination of 60 mg nifedipine + 32 mg candesartan (1 tablet in one period)

DRUG

Nifedipine (Adalat, BAY A1040) and Candesartan (Atacand, BAY 12-9333)

Loose combination of 1 tablet nifedpipine 60mg (Adalat LA) and 2 tablets candesartan 16mg (Atacand) (3 tablets in one period) .

Trial Locations (1)

Berlin